Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao Sells 90,000 Shares

Alignment Healthcare, Inc. (NASDAQ:ALHC) CEO John E. Kao sold 90,000 shares of the stock in a transaction on Monday, November 11th. The shares were sold at an average price of $13.42, for a total value of $1,207,800.00. Following the sale, the chief executive officer now directly owns 2,453,100 shares in the company, valued at $32,920,602. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Alignment Healthcare Trading Down 2.9 %

NASDAQ:ALHC traded down $0.38 during trading hours on Wednesday, hitting $12.78. 934,105 shares of the stock traded hands, compared to its average volume of 1,045,498. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $14.25. The stock has a 50 day moving average price of $11.43 and a 200 day moving average price of $9.26. The company has a debt-to-equity ratio of 1.82, a current ratio of 1.60 and a quick ratio of 1.60.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Tuesday, October 29th. The company reported ($0.14) EPS for the quarter, meeting the consensus estimate of ($0.14). Alignment Healthcare had a negative return on equity of 108.69% and a negative net margin of 5.84%. The business had revenue of $692.43 million for the quarter, compared to the consensus estimate of $662.11 million. During the same period in the previous year, the business earned ($0.19) earnings per share. The business’s revenue was up 51.6% on a year-over-year basis. Equities research analysts predict that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Institutional Investors Weigh In On Alignment Healthcare

Large investors have recently bought and sold shares of the business. Allspring Global Investments Holdings LLC raised its holdings in Alignment Healthcare by 9.2% during the 1st quarter. Allspring Global Investments Holdings LLC now owns 39,570 shares of the company’s stock valued at $196,000 after buying an additional 3,334 shares during the period. Vanguard Group Inc. lifted its holdings in shares of Alignment Healthcare by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 9,239,472 shares of the company’s stock worth $45,828,000 after acquiring an additional 93,262 shares during the last quarter. Hood River Capital Management LLC grew its holdings in Alignment Healthcare by 49.6% during the 1st quarter. Hood River Capital Management LLC now owns 2,920,836 shares of the company’s stock valued at $14,487,000 after purchasing an additional 968,637 shares during the last quarter. Jacobs Levy Equity Management Inc. purchased a new stake in shares of Alignment Healthcare in the first quarter worth approximately $918,000. Finally, Virtu Financial LLC bought a new stake in shares of Alignment Healthcare during the 1st quarter worth approximately $57,000. Institutional investors own 86.19% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently commented on ALHC. Robert W. Baird lifted their price target on shares of Alignment Healthcare from $10.00 to $11.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 14th. Stifel Nicolaus boosted their target price on shares of Alignment Healthcare from $9.00 to $12.00 and gave the company a “buy” rating in a research note on Friday, July 26th. Piper Sandler reissued an “overweight” rating and set a $10.00 price target (up from $8.00) on shares of Alignment Healthcare in a report on Tuesday, August 6th. TD Cowen lifted their price objective on Alignment Healthcare from $8.00 to $10.00 and gave the stock a “buy” rating in a report on Tuesday, August 6th. Finally, KeyCorp initiated coverage on Alignment Healthcare in a research report on Friday, October 11th. They set a “sector weight” rating for the company. One analyst has rated the stock with a sell rating, three have issued a hold rating, six have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $10.33.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.